期刊文献+

中耳胆脂瘤并发迷路瘘管和迟发性膜迷路积水1例 被引量:1

A case report of middle ear cholesteatoma complicated with labyrinthine fistulaand delayed endolymphatic hydrops
原文传递
导出
摘要 迟发性膜迷路积水(delayed endolymphatic hydrops,DEH)是引起眩晕一种不常见的疾病,在临床上不受重视容易误诊其他眩晕疾病。本文报道了1例容易误诊的眩晕患者。患者为中耳胆脂瘤并发迷路瘘管,然而其眩晕为发作性眩晕,不能用迷路瘘管导致迷路炎作为解释,怀疑合并有膜迷路积水可能,并经内耳MRI钆造影证实为膜迷路积水。首次报道了中耳胆脂瘤并发迷路瘘管和DEH的病例,经手术切除胆脂瘤同期行三半规管阻塞,术后随访2年内未再发作眩晕。对眩晕疾病的诊断,细致的眩晕病史询问至关重要。 Delayed endolymphatic hydrops(DEH)is a rare disease that causes vertigo and is often misdiagnosed as other vertigo diseases.This article reports on a patient with vertigo who was easily misdiagnosed.The patient was a middle ear cholesteatoma complicated by labyrinthine fistula(LF);however,his vertigo was episodic vertigo,which could not be explained solely by LF causing labyrinthitis.The possibility of endolymphatic hydrops was suspected,which was confirmed by inner ear magnetic resonance gadolinium imaging.This is the first reported case of middle ear cholesteatoma complicated by LF and DEH.The patient underwent surgical resection of the cholesteatoma and three semicircular canal obstructions at the same time.During two years postoperative follow-up,the patient did not experience a recurrence of vertigo.When diagnosing vertigo diseases,a careful history of vertigo is of utmost importance.
作者 林锋 吴倩如 张毅博 戴春富 LIN Feng;WU Qianru;ZHANG Yibo;DAI Chunfu(Department of Otorhinolaryngology,Fudan University Eye and ENT Hospital,Key Laboratory of Auditory Medicine of the National Health Commission,Shanghai,200031,China)
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2023年第8期670-672,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 迟发性膜迷路积水 迷路瘘管 中耳胆脂瘤 内耳MRI钆造影 膜迷路积水 delayed endolymphatic hydrops labyrinthine fistula middle ear cholesteatoma inner ear magnetic resonance gadolinium imaging endolymphatic hydrops
  • 相关文献

参考文献2

二级参考文献12

  • 1中华医学会耳鼻咽喉科学会.梅尼埃病诊断依据和疗效分级[J].中华耳鼻咽喉科杂志,1997,32:71-71.
  • 2BALKEY B W. Update on intratympanic gentamicin for Meniere's disease[J]. Laryngoscope, 2000, 110:236- 240.
  • 3HARNER S G, DRISCOLL C L, FACER G W, et al. Long-term follow-up of transtympanie gentamieinfor Menere's syndrome[J]. Otol Neurotol, 2001, 22:210-214.
  • 4WU I C, MINOR L B. Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere's disease[J]. Laryngoscope, 2003, 113:815 -820.
  • 5PENDER J D. Gentamicin tympanoclyisis effects on the labyrinthine sensory cells [J]. Laryngoscope,2003, 113:343-348.
  • 6Commttee on earing and equilibrium. Committee on hearing and equilibrium guildelines for the diagnosis and evaluation of therapy in Meniere's disease[J].Otolaryngol Head Neck Surg, 1995, 113:181-185.
  • 7MINOR L B. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy[J]. Am J Otol, 1999,20:209-219.
  • 8PEREZ N, MARTIN E, GARCIA-TAPIA R. Intratympanic gentamicin for intractable Meniere's disease[J]. Laryngoscope, 2003,113:456- 464.
  • 9万良财,郭梦和,谢南屏,文忠,陈浩,龚剑,陈帅君.慢性化脓性中耳炎合并迷路瘘管诊治体会(附32例报告)[J].中华耳科学杂志,2009,7(1):35-38. 被引量:5
  • 10周敬淳,龚桃根,柯朝阳,刘明.胆脂瘤型中耳炎并发迷路瘘管38例临床分析[J].中华耳科学杂志,2011,9(4):423-425. 被引量:4

共引文献21

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部